Live feed
Filing
SC 13G
SC 13G0000929638-14-000884·Akari Therapeutics Plc
Schedule 13G ownership disclosure
Celsus Therapeutics Plc.
Security class unavailable · CUSIP: 15119A103
Event date: 2014-11-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.3900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-14-000884
- Form type
- SC 13G
- Filer
- Akari Therapeutics Plc
- CIK
- CIK 1541157
- Filed
- Nov 24, 2014
- Reporting period
- Nov 07, 2014
- Description
- Schedule 13G beneficial ownership